Literature DB >> 2974325

Tyrosinaemia type II (Richner-Hanhart syndrome)--report of two cases treated with etretinate.

N G Fraser, J MacDonald, W A Griffiths, J L McPhie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2974325     DOI： 10.1111/j.1365-2230.1987.tb01944.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  2 in total

1.  Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Joyce Rebelo; Adriani P Damiani; Maiara Pereira; Vanessa M Andrade; Fernanda F Gava; Samira S Valvassori; Patricia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-03-18       Impact factor: 3.584

2.  Plantar keratoderma: a manifestation of tyrosinemia type II (Richner-Hanhart syndrome).

Authors:  Jihad T Al-Ratrout; Mohammed Al-Muzian; Mona Al-Nazer; Naseem A Ansari
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.